Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

14 Feb 2005 12:19

ReGen Therapeutics PLC14 February 2005 ReGen Therapeutics Plc DISCLOSURE OF NOTIFIABLE INTEREST - DISPOSAL OF SHARES London, UK - 14 February, 2005: ReGen Therapeutics Plc (the "Company") announcesthat on 11 February 2005 it received notification from New OpportunitiesInvestment Trust Plc that, following a disposal by it of 1,000,000 ordinaryshares of the Company on 10 February 2005, it now retains a holding of ordinaryshares of less than the Notifiable Interest level of 3% of the issued sharecapital of the Company. For further information, please contact: Andrew Marshall Tel. 020 7960 6007Marshall Robinson Roe This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.